Quick Answer
Universe Pharmaceuticals INC reported Net Income Loss of -$3.67 billion for the year ending 2025.
- Universe Pharmaceuticals INC showed an increase of +57.9% in Net Income Loss from 2024 to 2025.
- This data is from Universe Pharmaceuticals INC's annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Universe Pharmaceuticals INC's Net Income Loss has declined by 48,683.6%.
- Historical annual values: Fiscal year 2025: -$3.67 billion | Fiscal year 2024: -$8.73 billion | Fiscal year 2023: -$6.58 billion | Fiscal year 2022: -$7.91 million | Fiscal year 2021: $11.32 million | Fiscal year 2020: $7.56 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: